Hauptinhalt

Zehn ausgewählte Publikationen

• Doppler K, Jentschke H-M, Schulmeyer L, Vadasz D, Janzen A, Luster M, Höffken H, Mayer G, Brumberg J, Booij J, Musacchio T, Klebe S, Sittig-Wiegand E, Volkmann J, Sommer C, Oertel WH.
  Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson’s disease - a clinico-pathological biomarker study.
  Acta Neuropathol 2017; See comment in PubMed Commons below133(4): 535-545.
  
  
• Höglinger GU, Alvarez-Fischer D, Arias-Carrión O, Djufri M, Windolph A, Keber U, Borta A, Ries V, Schwarting RK, Scheller D, Oertel WH.
  A new dopaminergic nigro-olfactory projection.
  Acta Neuropathol 2015; 130(3): 333-348
  
  
• Oertel WH, Trenkwalder C, Benes H, Ferini-Strambi L, Högl B, Poewe W, Stiasny-Kolster K, Fichtner A, Schollmayer E, Kohnen R, García-Borreguero D; on behalf of the SP710 study group.
  Long-term safety and efficacy of rotigotine transdermal patch in moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study.
  Lancet Neurol 2011; 10(8): 710-720
  
  
• Stiasny-Kolster K, Doerr Y, Moeller JC, Hoeffken H, Behr TM, Oertel WH, Mayer G.
  Combination of ‘idiopathic’ REM sleep behaviour disorder and olfactory dysfunction as possible indicator for α-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.
  Brain 2005; 128: 126-137
  
  
• Dodel RC, Du Y, Depboylu C, Hampel H, Frölich L, Haag A, Hemmeter U, Paulsen S, Teipel SJ, Brettschneider S, Spottke A, Noelker C, Moeller HJ, Wei X, Farlow M, Sommer N, Oertel WH.
  Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer’s disease.
  J Neurol Neurosurg Psychiat 2004; 75:1472-1474
  
  
• Trenkwalder C, Stiasny K, Pollmächer T, Wetter T, Schwarz J, Kohnen R, Kazenwadel J, Krüger HP, Ramm S, Künzel M, Oertel WH.
  Movements during sleep: L-DOPA therapy of uremic and idiopathic restless legs syndrome: a double-blind crossover trial.
  Sleep 1995; 18: 681-688
  
  
• Sauer HJ, Oertel WH.
  Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.
  Neuroscience 1994; 59: 401-416
  
  
• Oertel WH, Gasser T, Ippisch R, Trenkwalder C, Poewe W.
  Apomorphine test for dopaminergic responsiveness.
  Lancet 1989; 3: 1262-1263 (Letter)
  
  
• Mugnaini E, Oertel WH.
  An atlas of the distribution of GABAergic neurons and terminals in the rat CNS as revealed by GAD immunohistochemistry.
  In: Björklund A, Hökfelt T (Eds). Handbook of Chemical Neuroanatomy, Vol. 4, Chapter X. Elsevier, Amsterdam, North Holland, 1985; 436-608
  
  
• Oertel WH, Schmechel DE, Tappaz ML, Kopin IJ.
  Production of a specific antiserum to rat brain glutamic acid decarboxylase by injection of an antigen-antibody complex.
  Neuroscience 1981; 6: 2689-2700